BioCentury | Mar 5, 2021
Deals
March 4 Quick Takes: Crossovers pour into Amunix’s $117M B round; plus funding for atai, BlossomHill, OnKure, Exscientia, CorVista, Blue Note and Geneos and deals for Takeda-Enzyre, ConserV-eTheRNA
...led by Viking Global Investors with participation by new investors Bain Capital Life Sciences, BlackRock, Franklin Templeton...